Pediatric detrusor overactivity can be treated with botulinum A toxin
This article has no abstract so we have provided the first paragraph of the full text.
Botulinum type A toxin (BTX-A) has been successfully used to treat detrusor overactivity in adults, but its efficacy in children is unknown. Its safety in the treatment of other pediatric disorders, however, has been proven. As detrusor overactivity is common in children, Hoebeke et al. tested the effectiveness of BTX-A in the treatment of pediatric, therapy-resistant, non-neurogenic detrusor overactivity.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Mycobacterial virulence and specialized secretion: same story, different endingNature Medicine News and Views (01 Mar 2007)